Urinary Tartaric Acid, a Biomarker of Wine Intake, Correlates with Lower Total and LDL Cholesterol.


Journal

Nutrients
ISSN: 2072-6643
Titre abrégé: Nutrients
Pays: Switzerland
ID NLM: 101521595

Informations de publication

Date de publication:
22 Aug 2021
Historique:
received: 01 07 2021
revised: 16 08 2021
accepted: 19 08 2021
entrez: 27 8 2021
pubmed: 28 8 2021
medline: 15 9 2021
Statut: epublish

Résumé

Postmenopausal women are at higher risk of developing cardiovascular diseases due to changes in lipid profile and body fat, among others. The aim of this study was to evaluate the association of urinary tartaric acid, a biomarker of wine consumption, with anthropometric (weight, waist circumference, body mass index (BMI), and waist-to-height ratio), blood pressure, and biochemical variables (blood glucose and lipid profile) that may be affected during the menopausal transition. This sub-study of the PREDIMED (Prevención con Dieta Mediterránea) trial included a sample of 230 women aged 60-80 years with high cardiovascular risk at baseline. Urine samples were diluted and filtered, and tartaric acid was analyzed by liquid chromatography coupled to electrospray ionization tandem mass spectrometry (LC-ESI-MS/MS). Correlations between tartaric acid and the study variables were adjusted for age, education level, smoking status, physical activity, BMI, cholesterol-lowering, antihypertensive, and insulin treatment, total energy intake, and consumption of fruits, vegetables, and raisins. A strong association was observed between wine consumption and urinary tartaric acid (0.01 μg/mg (95% confidence interval (CI): 0.01, 0.01),

Identifiants

pubmed: 34445043
pii: nu13082883
doi: 10.3390/nu13082883
pmc: PMC8399930
pii:
doi:

Substances chimiques

Biomarkers 0
Cholesterol, LDL 0
Tartrates 0
Cholesterol 97C5T2UQ7J
tartaric acid W4888I119H

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Interprofesional del vino
ID : PID2020-114022RB-I00
Organisme : Centro de Investigación Biomédica en Red-Fisiopatología de la Obesidad y Nutrición
ID : AGL2016- 75329-R
Organisme : Centro de Investigación Biomédica en Red-Fisiopatología de la Obesidad y Nutrición
Organisme : Instituto de Salud Carlos III
Organisme : Generalitat de Catalunya
ID : 2017SGR 196

Références

Br J Nutr. 2010 Jun;103(12):1808-16
pubmed: 20102675
Circ Res. 2019 Mar;124(5):779-798
pubmed: 30817261
Molecules. 2019 Oct 08;24(19):
pubmed: 31597344
JCI Insight. 2019 Mar 7;4(5):
pubmed: 30843880
Nutr J. 2012 Dec 14;11:109
pubmed: 23237668
Circulation. 2016 Jan 12;133(2):187-225
pubmed: 26746178
Bratisl Lek Listy. 2017;118(5):292-298
pubmed: 28516793
Cytokine. 2021 Oct;146:155629
pubmed: 34247040
Nutr J. 2013 Nov 15;12(1):147
pubmed: 24228901
J Proteome Res. 2018 Apr 6;17(4):1624-1635
pubmed: 29485285
Nutrients. 2021 Mar 09;13(3):
pubmed: 33803089
J Biomol Screen. 2011 Dec;16(10):1153-69
pubmed: 22086720
Ann Intern Med. 2006 Jul 4;145(1):1-11
pubmed: 16818923
Eur J Epidemiol. 2011 Nov;26(11):833-50
pubmed: 22076059
Stroke. 2017 Jan;48(1):70-76
pubmed: 27909203
Menopause. 2019 Oct;26(10):1213-1227
pubmed: 31568098
Am J Clin Nutr. 2008 Apr;87(4):957-63
pubmed: 18400719
Int J Mol Sci. 2018 Dec 11;19(12):
pubmed: 30544955
Public Health Nutr. 2011 Dec;14(12A):2274-84
pubmed: 22166184
Circulation. 2009 Oct 20;120(16):1640-5
pubmed: 19805654
N Engl J Med. 2000 Jul 6;343(1):16-22
pubmed: 10882764
Int J Epidemiol. 2012 Apr;41(2):377-85
pubmed: 21172932
Health Econ. 2010 Jul;19(7):814-32
pubmed: 19548203
Circulation. 2019 Mar 5;139(10):e56-e528
pubmed: 30700139
Metabolism. 2018 Jun;83:102-119
pubmed: 29408458
Med Sci Sports Exerc. 2000 Aug;32(8):1431-7
pubmed: 10949009
Clin Nutr ESPEN. 2015 Dec;10(6):e224-e233
pubmed: 28531467
Atherosclerosis. 2010 Feb;208(2):297-304
pubmed: 19660752
J Am Coll Cardiol. 2009 Dec 15;54(25):2366-73
pubmed: 20082925
Br J Nutr. 2014 May;111(9):1680-5
pubmed: 24507823
Pharmacol Res. 2012 Jun;65(6):615-20
pubmed: 22465220
J Agric Food Chem. 2013 Jul 10;61(27):6763-8
pubmed: 23777193
Prostaglandins Other Lipid Mediat. 2017 May;130:23-29
pubmed: 28323197
Diabetes Care. 2018 Jan;41(Suppl 1):S13-S27
pubmed: 29222373
Nutr Metab Cardiovasc Dis. 2011 Sep;21(9):733-9
pubmed: 21194913
Int J Epidemiol. 1990 Mar;19(1):42-8
pubmed: 2351523
Alcohol Alcohol. 2013 May-Jun;48(3):270-7
pubmed: 23408240
Public Health Nutr. 2005 May;8(3):315-20
pubmed: 15918929
Br J Nutr. 2015 Apr;113 Suppl 2:S121-30
pubmed: 26148915
Mol Nutr Food Res. 2012 Feb;56(2):345-51
pubmed: 22419533
J Nutr. 2003 Mar;133 Suppl 3:881S-887S
pubmed: 12612174
Metabolomics. 2019 May 2;15(5):72
pubmed: 31049735
Menopause. 2019 Nov;26(11):1327-1333
pubmed: 31567869
Int J Cardiol. 2017 Jan 15;227:788-794
pubmed: 28029409
Anal Chim Acta. 2009 Feb 16;634(1):54-60
pubmed: 19154810
Ann Med. 2011 Nov;43(7):545-54
pubmed: 21599573
Int J Food Sci Nutr. 2005 Aug;56(5):303-7
pubmed: 16236591
Obes Facts. 2008;1(2):80-7
pubmed: 20054166

Auteurs

Inés Domínguez-López (I)

Department of Nutrition, Food Science and Gastronomy, XIA, School of Pharmacy and Food Sciences, INSA, University of Barcelona, 08028 Barcelona, Spain.
Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain.

Isabella Parilli-Moser (I)

Department of Nutrition, Food Science and Gastronomy, XIA, School of Pharmacy and Food Sciences, INSA, University of Barcelona, 08028 Barcelona, Spain.
Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain.

Camila Arancibia-Riveros (C)

Department of Nutrition, Food Science and Gastronomy, XIA, School of Pharmacy and Food Sciences, INSA, University of Barcelona, 08028 Barcelona, Spain.

Anna Tresserra-Rimbau (A)

Department of Nutrition, Food Science and Gastronomy, XIA, School of Pharmacy and Food Sciences, INSA, University of Barcelona, 08028 Barcelona, Spain.
Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain.

Miguel Angel Martínez-González (MA)

Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain.
Department of Preventive Medicine and Public Health, School of Medicine, University of Navarra, 31008 Pamplona, Spain.
Department of Nutrition, Harvard TH Chan School of Public Health, Boston, MA 02115, USA.

Carolina Ortega-Azorín (C)

Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain.
Department of Preventive Medicine and Public Health, School of Medicine, University of Valencia, 46010 Valencia, Spain.

Jordi Salas-Salvadó (J)

Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain.
Unitat de Nutrició Humana, Departament de Bioquímica i Biotecnologia, Hospital Universitari San Joan de Reus, Universitat Rovira i Virgili, 43201 Reus, Spain.
Institut d'Investigació Sanitària Pere Virgili (IISPV), 43201 Reus, Spain.

Olga Castañer (O)

Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain.
Cardiovascular Epidemiology Unit, Municipal Institute for Medical Research (IMIM), 08007 Barcelona, Spain.

José Lapetra (J)

Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain.
Research Unit, Department of Family Medicine, Distrito Sanitario Atención Primaria Sevilla, 41010 Sevilla, Spain.

Fernando Arós (F)

Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain.
Department of Cardiology, Hospital Txangorritxu, 01009 Vitoria, Spain.

Miquel Fiol (M)

Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain.
Institut Universitari d'Investigació en Ciències de la Salut (IUNICS), 07122 Palma de Mallorca, Spain.

Lluis Serra-Majem (L)

Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain.
Department Clinical Sciences, University of Las Palmas de Gran Canaria, 35016 Palmas de Gran Canaria, Spain.

Xavier Pintó (X)

Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain.
Lipid Unit, Department of Internal Medicine, IDIBELL-Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, FIPEC, 08908 Barcelona, Spain.

Enrique Gómez-Gracia (E)

Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain.
Department of Epidemiology, School of Medicine, University of Malaga, 29010 Málaga, Spain.

Emilio Ros (E)

Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain.
Lipid Clinic, Endocrinology and Nutrition Service, Institut d'Investigacions Biomèdiques August Pi Sunyer (IDIBAPS), Hospital Clínic, 08036 Barcelona, Spain.

Rosa M Lamuela-Raventós (RM)

Department of Nutrition, Food Science and Gastronomy, XIA, School of Pharmacy and Food Sciences, INSA, University of Barcelona, 08028 Barcelona, Spain.
Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain.

Ramon Estruch (R)

Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN), Instituto de Salud Carlos III, 28029 Madrid, Spain.
Internal Medicine Department, Institut d'Investigacions Biomèdiques August Pi Sunyer (IDIBAPS), Hospital Clinic, University of Barcelona, 08036 Barcelona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH